VANCOUVER, June 11, 2019 /CNW/ – THC BioMed Intl Ltd. (“THC BioMed“, or the “Company“) (CSE: THC) is pleased to announce that it is the first Canadian Licensed Producer to automate the pre-rolling of cigarettes containing 100% cannabis (the “Pure Cannabis Cigarettes”). In the same way automation changed the tobacco industry, THC BioMed is confident the automation of Pure Cannabis Cigarettes will bring meaningful changes to the current cannabis industry and its bottom line.
The automated cigarette manufacturing plant has been installed at THC BioMed’s flagship Acland Road location. THC will begin the production and sales of commercial-grade Pure Cannabis Cigarettes, a first in Canada.
The Pure Cannabis Cigarettes are to be packaged in lots of 3 and 20. Each Pure Cannabis Cigarette will be intended for a single-use session and will come with a commercial-grade cigarette filter. There will be no tobacco in the Pure Cannabis Cigarettes.
“We are very pleased to offer Canadians a better way of smoking cannabis, as we monitored an increase in demand for our best-selling pre-rolls, we acknowledged that it was our duty to ensure we distribute the best products possible. We are pleased to be the first cannabis producer to put filters between the cannabis we are selling, and our consumers. Filters were invented to protect the consumer and not degrade the experience. “We promise our Pure Cannabis Cigarettes will offer the same potency as our regular best-selling pre-rolls. I am predicting consumers will gravitate towards this finished type of product and the old way of rolling joints will be something of the past,” said John Miller, President and CEO of THC BioMed.
The automated cigarette manufacturing plant is capable of producing up to 5,000 cigarettes per minute.
“We also expect our CBD line of Pure Cannabis Cigarettes to be very popular, as we expect regular cigarette users will find it easier to transition to our CBD product, which we think is better than smoking tobacco,” said Mr. Miller, “Automating our systems now gives us a clear path to profitability. We work diligently to bring shareholder value through more traditional and tested ways such as being a profitable company, patience is required.”
THC plans to offer the following strains in Pure Cannabis Cigarette form, other strains may follow:
THC Sativa Landrace;
THC Indica Landrace;
THC Hybrid Landrace; and,
THC expects its Pure Cannabis Cigarettes to be available soon via its website for medical patients and through provinces with distribution agreements with THC.
THC is an ACMPR Licensed Producer and Canada’s largest supplier of legal Cannabis Genetics. THC is on the leading edge of scientific research and the development of products and services related to the medical cannabis industry. Management believes THC is well-positioned to be in the forefront of this rapidly growing industry. Please visit our website for a more detailed description of our business and services available. www.thcbiomed.com.
President and CEO:
The Canadian Securities Exchange (CSE) has not reviewed and does not accept responsibility for the adequacy or the accuracy of the contents of this release.
This press release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business of THC BioMed. Forward-looking information is based on certain key expectations and assumptions made by the management of THC BioMed. In some cases, you can identify forward-looking statements by the use of words such as “will,” “may,” “would,” “expect,” “intend,” “plan,” “seek,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “continue,” “likely,” “could” and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Although THC BioMed believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because THC BioMed can give no assurance that they will prove to be correct. Forward-looking statements contained in this press release are made as of the date of this press release and include that it will be the first Canadian Licensed Producer to automate the pre-rolling of cigarettes containing 100% cannabis, the automation of Pure Cannabis Cigarettes will bring meaningful changes to the current cannabis industry and its bottom line, the Pure Cannabis Cigarettes will look as illustrated in the photo, each Pure Cannabis Cigarette will come with a commercial-grade cigarette filter, Pure Cannabis Cigarettes will offer the same potency as THC BioMed’s regular best-selling pre-rolls, consumers will gravitate towards this finished type of product and the old way of rolling joints will be something of the past, The automated cigarette manufacturing plant will produce up to 5,000 cigarettes per minute, the CBD line of Pure Cannabis Cigarettes will be very popular, regular cigarette users will find it easier to transition to the CBD product, THC will offer the listed strains in Pure Cannabis Cigarette form, Pure Cannabis Cigarettes to be available soon via THC BioMed’s website for medical patients and through provinces with distribution agreements with THC BioMed. THC BioMed disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.
SOURCE THC BioMed